The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 2.8M data for 1.2M Compounds and 9.2K Targets. Of those, 1,346K data for 622K Compounds and 4.5K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

9 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Topographical amino acid substitution in position 10 of glucagon leads to antagonists/partial agonists with greater binding differences.EBI
University Of Arizona
A study on the contribution of the 1-phenyl substituent to the molecular electrostatic potentials of some benzazepines in relation to selective dopamine D-1 receptor activity.EBI
University Of Lund
Conformational analysis and structure-activity relationships of selective dopamine D-1 receptor agonists and antagonists of the benzazepine series.EBI
Royal Danish School Of Pharmacy
Biaryl amide glucagon receptor antagonists.EBI
Abbott Laboratories
Metal coordination-based inhibitors of adenylyl cyclase: novel potent P-site antagonists.EBI
Millennium Pharmaceuticals
Hydroxamate based inhibitors of adenylyl cyclase. Part 2: the effect of cyclic linkers on P-site binding.EBI
Millennium Pharmaceuticals
Hydroxamate based inhibitors of adenylyl cyclase. Part 1: the effect of acyclic linkers on P-site binding.EBI
Millennium Pharmaceuticals
6-Bicyclopiperazinyl-1-arylsulfonylindoles and 6-bicyclopiperidinyl-1-arylsulfonylindoles derivatives as novel, potent, and selective 5-HT6 receptor antagonists.EBI
Nps Allelix
Dicarbavasopressin antagonist analogues exhibit reduced in vivo agonist activity.EBI
Smith Kline & French Laboratories